发明申请
US20130237564A1 Combinations of Glycopyrrolate and Beta2 Adrenoceptor Agonists 审中-公开
乙酰胆碱酯酶和β2肾上腺素受体激动剂的组合

  • 专利标题: Combinations of Glycopyrrolate and Beta2 Adrenoceptor Agonists
  • 专利标题(中): 乙酰胆碱酯酶和β2肾上腺素受体激动剂的组合
  • 申请号: US13862529
    申请日: 2013-04-15
  • 公开(公告)号: US20130237564A1
    公开(公告)日: 2013-09-12
  • 发明人: Stephen Paul Collingwood
  • 申请人: Stephen Paul Collingwood
  • 申请人地址: CH Basel
  • 专利权人: Novartis AG
  • 当前专利权人: Novartis AG
  • 当前专利权人地址: CH Basel
  • 优先权: GB0411056.5 20040518
  • 主分类号: A61K31/4704
  • IPC分类号: A61K31/4704 A61K31/40
Combinations of Glycopyrrolate and Beta2 Adrenoceptor Agonists
摘要:
A medicament comprising, separately or together (A) glycopyrrolate; and (B) either a compound of formula I in free or salt or solvate form, wherein W, Rx, Ry, R1, R2, R3, R4, R5, R6 and R7 have the meanings as indicated in the specification, or a compound of formula II in free or salt or solvate form, wherein X has the meaning as indicated in the specification, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease. Pharmaceutical compositions that contain (A) and (B) are also described.
信息查询
0/0